FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Radical Muslim Kills Gay Pro-Palestine Activist Outside Gay Bar

WJ Straw Poll: Rubio Surges to Commanding Lead, Vance Cruises Past Massie

Alleged cryptoscam ringleader set for plea hearing in $240M bitcoin theft

Sherrill anti-ICE policy hammered after fleeing migrant driver injures Dem mayor’s wife

New California Bill Could Completely Disqualify Former ICE Agents from Public Employment

‘We’re Scared, Very Scared’: Weeping Spanish Girl Reveals Heartbreaking Reality of Mass Migration from Africa

Sen Jim Justice finds way through Senate polarization to bring WWII hero memorial to DC

Israel’s ambassador says NYC’s Mamdani is ‘sowing chaos’ ahead of Netanyahu’s UN appearance

Gary Sinise 9/11 documentary wants to inspire Americans with hope

Florida AG seeks death penalty for couple who allegedly held 4 children in ‘rolling prison’ for nearly 7 years

Former USCIS official, accomplice charged in alleged $960K citizenship bribery scheme

Dramatic video captures floodwaters bursting through glass doors of college students’ home

Trump appears to debut darker hair, sparking online buzz

Breaking: Deadly Amazon Cargo Plane Crash at Miami Airport Leaves 5 Dead

Amy Acton campaign says armed individual lunged at Ohio governor candidate, injuring multiple people

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”